ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG – Trademark Portfolio
Entity Type: 13
ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ALPECIN. The owner is based in 4800 BIELEFELD 1.
SUDBRACKSTRASSE 56
4800 BIELEFELD 1 , DE
Showing of trademarks Trademarks
Trademark Classifications
ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG have?
ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG file in?
ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG's most well-known trademarks?
ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG's registered trademark portfolio includes well-known marks such as ALPECIN. These are among 1 currently registered trademark in the portfolio.
What is ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG's trademark registration success rate?
ALCINA KOERPERPFLEGEMITTEL DR. KURT WOLFF GMBH AND CO. KG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.